Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial tight and adherens junction proteins constitute the apical junctional complex (AJC), which serves as the primary physical barrier between the intestinal lumen and the underlying mucosal immune system. Tight junctions, including claudins, occludin, and zonula occludens proteins, regulate paracellular permeability and maintain cell polarity, while adherens junctions, featuring E-cadherin and catenins, provide the adhesive strength necessary for tissue integrity (PMID: 23303615, 28461160). Disruption of these junctional complexes is a central feature in the pathogenesis of inflammatory bowel disease (IBD), celiac disease, and irritable bowel syndrome, where 'leaky gut' allows for the translocation of luminal antigens that trigger chronic inflammation (PMID: 22314561). Pharmacological modulation of these proteins, such as through zonulin antagonists like larazotide acetate or growth factors like glucagon-like peptide-2 (GLP-2) analogs, aims to seal the barrier and reduce systemic inflammatory triggers. Consequently, these proteins are high-priority targets for drug development in gastroenterology and autoimmune research.
Modulation of paracellular permeability through the regulation of tight junction assembly, antagonism of zonulin-mediated disassembly, and enhancement of junctional protein expression and localization.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial tight and adherens junction proteins (AJC).